Soyer, NAli, RTurgut, MHaznedaroglu, IYilmaz, FAydogdu, IPir, AKarakus, VOzgur, GKis, CCeran, FIlhan, GOzkan, MArslaner, MInce, I2025-04-102025-04-100145-2126http://hdl.handle.net/20.500.14701/43006EnglishRetrospective and multicenter analysis of efficacy and safety of ruxolitinib in 176 Turkish patients with myelofibrosis: updated dataMeeting Abstract1873-5835